John Geisler

John Geisler

Company: Mitochon Pharmaceuticals

Job title: Chief Scientific Officer

Seminars:

ALS, Secondary Progressive MS & Alzheimer’s Disease: Commonly Rooted in Mitochondrial Dysfunction in a 14-Day MP-101 Clinical CSF Biomarker Basket Study 11:00 am

MP-101: Lowers damage while promoting repair MP-101: Mitochondrial-specific, biophysics MOA, non-genomic pharmacology cascading into cellular remodeling MP-101: Oral brain penetrating once-per-day treatment waking up compensatory mechanism Pro-SurvivalRead more

day: CONFERENCE DAY ONE

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.